Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ARDMQ
Aradigm
$0.05
$0.05
$0.02
$0.20
$764KN/A21,923 shsN/A
Cutera, Inc. stock logo
CUTR
Cutera
$0.04
-63.9%
$0.04
$0.09
$1.87
$787K1.362.80 million shs27.70 million shs
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
$0.00
-50.0%
$0.00
$0.00
$0.00
N/A-1.356.91 million shs10,030 shs
NIMU
Non-Invasive Monitoring Systems
$0.00
$0.01
$0.00
$0.02
$630K0.975,530 shsN/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ARDMQ
Aradigm
0.00%0.00%0.00%0.00%0.00%
Cutera, Inc. stock logo
CUTR
Cutera
0.00%0.00%0.00%0.00%-96.98%
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
0.00%-50.00%-50.00%-50.00%-88.89%
NIMU
Non-Invasive Monitoring Systems
0.00%-22.64%-31.67%+2.50%-65.25%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ARDMQ
Aradigm
N/AN/AN/AN/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
N/AN/AN/AN/AN/AN/AN/AN/A
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ARDMQ
Aradigm
0.00
N/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
2.50
Moderate Buy$3.007,592.31% Upside
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
0.00
N/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ARDMQ
Aradigm
N/AN/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
$155.21M0.01N/AN/A($8.62) per share0.00
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
$10K12.07N/AN/A($0.08) per share0.00
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/A($0.01) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ARDMQ
Aradigm
N/AN/A0.00N/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
-$162.83M-$6.58N/AN/AN/A-84.86%N/A-45.07%8/6/2025 (Estimated)
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
-$2.80MN/A0.00N/AN/AN/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
-$110KN/A0.00N/AN/AN/A-251.43%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ARDMQ
Aradigm
N/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
N/AN/AN/AN/AN/A
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/AN/AN/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ARDMQ
Aradigm
N/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
N/A
2.88
1.86
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
N/A
0.03
0.03

Institutional Ownership

CompanyInstitutional Ownership
ARDMQ
Aradigm
N/A
Cutera, Inc. stock logo
CUTR
Cutera
90.70%
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/A
NIMU
Non-Invasive Monitoring Systems
0.12%

Insider Ownership

CompanyInsider Ownership
ARDMQ
Aradigm
4.50%
Cutera, Inc. stock logo
CUTR
Cutera
0.42%
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
5.61%
NIMU
Non-Invasive Monitoring Systems
28.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
ARDMQ
Aradigm
2315.28 millionN/ANot Optionable
Cutera, Inc. stock logo
CUTR
Cutera
46020.19 million20.10 millionOptionable
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
11.21 billion1.14 billionNot Optionable
NIMU
Non-Invasive Monitoring Systems
3154.81 million110.23 millionNot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Aradigm OTCMKTS:ARDMQ

$0.05 0.00 (0.00%)
As of 06/30/2020

Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung.

Cutera stock logo

Cutera NASDAQ:CUTR

$0.04 -0.07 (-63.86%)
Closing price 03/12/2025
Extended Trading
$0.04 0.00 (0.00%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

Endonovo Therapeutics stock logo

Endonovo Therapeutics OTCMKTS:ENDV

$0.0001 0.00 (-50.00%)
As of 07/3/2025 11:17 AM Eastern

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

Non-Invasive Monitoring Systems OTCMKTS:NIMU

$0.0041 0.00 (0.00%)
As of 07/3/2025

Non-Invasive Monitoring Systems, Inc. does not have significant operations. Previously, it was involved in the research, development, manufacture, marketing, and sale of non-invasive, motorized, and whole body periodic acceleration platforms. The company was incorporated in 1980 and is based in Miami, Florida.